Journal of Medicinal Chemistry p. 2011 - 2032 (1994)
Update date:2022-07-30
Topics:
Sheppard, George S.
Pireh, Daisy
Carrera, George M.
Bures, Mark G.
Heyman, H. Robin
et al.
(2RS,4R)-3-(2-(3-pyridinyl)thiazolidin-4-oyl)indoles represent a new class of potent, orally active antagonists of platelet activating factor (PAF). The compounds were prepared by acylation of the magnesium or zinc salts of substituted indoles with (2RS,4R)-2-(3-pyridinyl)-3-(tert-butoxycarbonyl)thiazolidin-4-oyl chloride. The 3-acylindole moiety functions as a hydrolytically stabilized and conformationally restricted anilide replacement, which imparts a considerable boost in potency to the series. Structure-activity relationships observed for substitution on the indole ring system are discussed. Members of the series compare favorably with other reported PAF antagonists.
View MoreShanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
Contact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Zhuzhou Farshine Chemical Industry Co., Ltd
Contact:0086-731-28482786
Address:No. 1,Shui Xian Road, He Tang Dictrict,Hunan-412000,China
Valiant Fine Chemicals Co., Ltd.
Contact:+86 535 6101878/6374484
Address:11 Wuzhishan Rd.,YTETDZ,Yantai,264006,Shandong,China
Doi:10.1002/chem.201302651
(2014)Doi:10.1021/jm00048a018
(1994)Doi:10.1016/j.bmcl.2017.11.049
(2018)Doi:10.1134/S107036321207016X
(2012)Doi:10.1021/jm00002a002
(1995)Doi:10.1039/DT9940002783
(1994)